Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications.

Skin therapy letter, 2022 - europepmc.org
Janus kinase inhibitors, also commonly referred to as JAK inhibitors, are a novel drug class
that target and block cytokine signaling mediated by the Janus kinase-signal transducer and …
被引用次数：28 相关文章

Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications

MMK Shalabi, B Garcia, K Coleman… - Skin therapy …, 2022 - pubmed.ncbi.nlm.nih.gov
Janus kinase inhibitors, also commonly referred to as JAK inhibitors, are a novel drug class
that target and block cytokine signaling mediated by the Janus kinase-signal transducer and …